Cylindroma  >>  oxaliplatin  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
NCT00101075: Title XELOX FOR SALIVARY GLAND CANCERS

Terminated
2
9
US
Capecitabine, Xeloda, Oxaliplatin, Eloxatin
Dana-Farber Cancer Institute, National Cancer Institute (NCI), Sanofi-Synthelabo
Head and Neck Cancer
03/07
03/08
NCT00448552: Oxaliplatin and Capecitabine in Treating Patients With Relapsed or Metastatic Head and Neck Cancer

Completed
2
30
US
capecitabine, oxaliplatin
University of Miami
Head and Neck Cancer
04/07
06/08

Download Options